Relay Therapeutics, Inc. (RLAY) Dividend History
Income profile from 2018 to 2025 with payout safety and yield-on-cost trend
3-Second Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
Dividend History
No dividend payment history available
Dividend Analysis
Payout Safety
Relay Therapeutics, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 5/9 — moderate financial health.
Growth Track Record
RLAY does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, RLAY returns capital through share repurchases. The combined picture: 0.1% buyback yield, 0.1% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -74.5%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $2,927 today.
Dividend Peer Comparison
Peer group: Oncology Therapeutics Developers
Annual Dividend History
8 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $-1.61 | — | — | — |
| 2024 | $0.00 | — | 0 | $-2.36 | — | — | — |
| 2023 | $0.00 | — | 0 | $-2.79 | — | — | — |
| 2022 | $0.00 | — | 0 | $-2.59 | — | — | — |
| 2021 | $0.00 | — | 0 | $-3.82 | — | — | — |
| 2020 | $0.00 | — | 0 | $-2.56 | — | — | — |
| 2019 | $0.00 | — | 0 | $-15.53 | — | — | — |
| 2018 | $0.00 | — | 0 | $-19.63 | — | — | — |
See RLAY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RLAY Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare RLAY vs AGIO
See how RLAY stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How much dividend does RLAY pay per share?
Relay Therapeutics, Inc. (RLAY) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is RLAY's next ex-dividend date?
RLAY's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. RLAY typically pays dividends quarterly.
Is RLAY's dividend safe?
RLAY's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has RLAY increased its dividend?
RLAY has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does RLAY pay dividends?
Relay Therapeutics, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 7+ years from 2018 to 2025.
How much would $10,000 invested in RLAY grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in RLAY five years ago would be worth approximately $2,553 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is RLAY's yield on cost for long-term holders?
RLAY's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.